TEL AVIV, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TA

Teva wins FDA approval for Weltruza, the first once-monthly subcutaneous olanzapine injection for ad

Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growt

The U.S. Food and Drug Administration (FDA) recently approved Teva Pharmaceutical Industries Ltd. (N

FDA approves Teva's Weltruza, a once-monthly injectable for adults with schizophrenia, eliminati

Teva Pharmaceutical Industries NYSE: TEVA said the U.S. Food and Drug Administration has approved WE

Teva said on Friday it ​had received approval ‌from the US Food and Drug ​Administration for ​its We

WELTRUZA clinical trial results demonstrated improvement in symptoms (PANSS), significant reduction

WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthl

Based on a post hoc analysis, a majority of participants (~70%) experienced clinically meaningful ti

The published review examines dopamine’s role in tic generation and how approved and investigational

PARSIPPANY, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva P

PARSIPPANY, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva P

Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with

TD Cowen initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy rating and announc

Wall Street analysts reshuffled their bets on energy giants, homebuilders, and emerging space plays

INCHEON, Korea & TEL AVIV, Israel--(BUSINESS WIRE)-- #Fasenra--Samsung Bioepis Co., Ltd. and Teva Ph

TEL AVIV, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- TAPI (Technology & API Services) today announce

Teva's branded drugs are driving stronger growth as Austedo, Ajovy and Uzedy gain momentum and its p

Forecasts call for Teva's branded drug portfolio to bring it $3.7 billion in revenue next year. At t

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Dru

TEL AVIV, Israel, and PARSIPPANY, N.J., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Indus

QRG Capital Management Inc. grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) by

Teva Pharmaceutical Industries (NYSE: TEVA) is planning for greater financial flexibility after rece

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Indust

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Indust

Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conferen

Oppenheimer analyst Les Sulewski initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with

New data revealed that healthcare providers prioritize drowsiness risk, duration of available data d

New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables

In a post hoc analysis of the open-label safety stage of the Phase 3 SOLARIS trial, more than half o

The U.S. FDA approved Ocrevus for paediatric RMS patients in May 2026. A final decision from the Eur

Teva Pharmaceutical Industries had a busy week that included a major debt refinancing, a NYSE tradin

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it s

Leerink Partners analyst Daniel Clark initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA)

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises t

Teva reports positive Phase 2a results for TEV '408, successfully preventing gluten-induced inte

Teva Pharma is trading higher after announcing positive topline results from a Phase 2a study of TEV

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive topline results f

Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),

https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-wi

BioXcel Chapter 11 sends BTAI shares sharply lower as Teva becomes the stalking horse bidder for IGA

Aurinia Pharmaceuticals shares rise after settling patent litigation with Teva, which can launch gen

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) today announced that it and its subsidiary, Aurinia Pharm

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),

Barclays analyst Glen Santangelo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweigh

Teva revenue tops estimates despite an earnings miss. The company raises 2026 sales guidance and hig

Teva Pharmaceutical Indus (NYSE:TEVA) lowers FY2026 Adj EPS guidance from $2.57-$2.77 to $1.91-$2.11

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.02 per share which missed th